Staley Julie K, Gottschalk Christopher, Petrakis Ismene L, Gueorguieva Ralitza, O'Malley Stephanie, Baldwin Ronald, Jatlow Peter, Verhoeff Nicolaas Paul L G, Perry Edward, Weinzimmer David, Frohlich Erin, Ruff Elizabeth, van Dyck Christopher H, Seibyl John P, Innis Robert B, Krystal John H
Yale University School of Medicine, 950 Campbell Avenue, New Haven, CT 06516, USA.
Arch Gen Psychiatry. 2005 Aug;62(8):877-88. doi: 10.1001/archpsyc.62.8.877.
Adaptations in gamma-aminobutyric acid type A (GABA(A))-benzodiazepine receptors contribute to the neurobiology of human alcohol dependence and withdrawal.
To study GABA(A)-benzodiazepine receptor adaptations in subjects with alcohol dependence over the first month of sobriety.
Inpatients who were not receiving medication, were either smokers or nonsmokers, and had alcohol dependence completed 2 iodine I 123-labeled iomazenil single-photon emission computed tomographic scans: 1 scan at a mean +/- SD of 4.9 +/- 2.5 days of sobriety (n = 23) and 1 scan at a mean +/- SD of 29.8 +/- 7.6 days of sobriety (n = 20). Participants in a matched group of healthy subjects (n = 15) completed 1 single-photon emission computed tomographic scan.
Men with alcohol dependence (n = 27) and a matched healthy comparison group (n = 15).
(123)I-iomazenil single-photon emission computed tomographic images were converted to units of distribution volume (regional activity/free (123)I-iomazenil) and were analyzed using voxel-based statistical parametric mapping and regions of interest analyses. The relationships between (123)I-iomazenil distribution volume, clinical features of alcohol dependence, and smoking status were evaluated.
(123)I-iomazenil uptake was elevated in several cortical regions, with a more prominent increase in nonsmokers with alcohol dependence as compared with smokers with alcohol dependence at 1 week of abstinence from alcohol. No significant differences were observed at 4 weeks of abstinence. At 1 week of abstinence, frontal (123)I-iomazenil uptake correlated with the severity of alcohol withdrawal and the number of days since the last alcoholic drink was consumed. No significant associations were observed for smokers with alcohol dependence.
These data demonstrate time-dependent regulation of cortical GABA(A)-benzodiazepine receptors associated with the recovery from alcohol dependence. Higher GABA(A)-benzodiazepine receptor levels during acute withdrawal may reflect a compensation for reduced receptor function, which is thought to contribute to alcohol tolerance and withdrawal. The subsequent decline may reflect "normalization" of GABA(A) receptor function with sobriety. Smoking may attenuate GABA(A) receptor adaptations associated with alcohol dependence and may contribute to the comorbidity between alcoholism and smoking.
γ-氨基丁酸A型(GABA(A))-苯二氮䓬受体的适应性变化与人类酒精依赖和戒断的神经生物学有关。
研究戒酒第一个月内酒精依赖者的GABA(A)-苯二氮䓬受体适应性变化。
未接受药物治疗、有吸烟或不吸烟且患有酒精依赖的住院患者完成了2次碘I 123标记的艾美拉唑单光子发射计算机断层扫描:1次扫描在戒酒平均±标准差4.9±2.5天(n = 23)时进行,另1次扫描在戒酒平均±标准差29.8±7.6天(n = 20)时进行。一组匹配的健康受试者(n = 15)完成了1次单光子发射计算机断层扫描。
酒精依赖男性(n = 27)和一组匹配的健康对照组(n = 15)。
将(123)I-艾美拉唑单光子发射计算机断层扫描图像转换为分布容积单位(区域活性/游离(123)I-艾美拉唑),并使用基于体素的统计参数映射和感兴趣区域分析进行分析。评估了(123)I-艾美拉唑分布容积、酒精依赖的临床特征和吸烟状态之间的关系。
在戒酒1周时,几个皮质区域的(123)I-艾美拉唑摄取增加,与吸烟的酒精依赖者相比,不吸烟的酒精依赖者增加更为显著。在戒酒4周时未观察到显著差异。在戒酒1周时,额叶(123)I-艾美拉唑摄取与酒精戒断的严重程度以及自最后一次饮酒以来的天数相关。对于吸烟的酒精依赖者未观察到显著关联。
这些数据表明与酒精依赖恢复相关的皮质GABA(A)-苯二氮䓬受体存在时间依赖性调节。急性戒断期间较高的GABA(A)-苯二氮䓬受体水平可能反映了对受体功能降低的一种补偿,这被认为有助于酒精耐受性和戒断。随后的下降可能反映了随着戒酒GABA(A)受体功能的“正常化”。吸烟可能会减弱与酒精依赖相关的GABA(A)受体适应性变化,并可能导致酒精中毒和吸烟之间的共病。